Tissue Repair Ltd (TRP.AX)
AUD 0.22
(1.38%)
AUD 0.22
(1.38%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -4.87 Million AUD | 15.06% |
| 2023 | -5.74 Million AUD | 16.05% |
| 2022 | -6.83 Million AUD | -968.87% |
| 2021 | -639.7 Thousand AUD | -42.56% |
| 2020 | -448.72 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -1.17 Million AUD | 0.0% |
| 2024 Q2 | -2.53 Million AUD | -100.0% |
| 2024 Q1 | -1.26 Million AUD | 46.24% |
| 2024 FY | -6.51 Million AUD | -13.52% |
| 2024 Q3 | -1.17 Million AUD | 53.55% |
| 2023 Q1 | -1.69 Million AUD | 29.55% |
| 2023 FY | -5.74 Million AUD | 16.05% |
| 2023 Q4 | -2.35 Million AUD | -239.59% |
| 2023 Q3 | -693.87 Thousand AUD | 79.5% |
| 2023 Q2 | -3.38 Million AUD | -100.0% |
| 2022 FY | -6.83 Million AUD | -968.87% |
| 2022 Q4 | -2.4 Million AUD | -115.42% |
| 2022 Q3 | -1.11 Million AUD | 38.86% |
| 2022 Q2 | -1.82 Million AUD | -100.0% |
| 2022 Q1 | -911.85 Thousand AUD | -608.51% |
| 2021 Q1 | -115.56 Thousand AUD | 0.0% |
| 2021 FY | -639.7 Thousand AUD | -42.56% |
| 2021 Q4 | -128.7 Thousand AUD | 0.0% |
| 2021 Q3 | -128.7 Thousand AUD | -11.37% |
| 2021 Q2 | -115.56 Thousand AUD | 0.0% |
| 2020 FY | -448.72 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 7.329% |
| Acrux Limited | -9.83 Million AUD | 50.417% |
| Actinogen Medical Limited | -12.83 Million AUD | 62.022% |
| AnteoTech Limited | -11.72 Million AUD | 58.42% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 14.023% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 32.213% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -234.169% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 75.125% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -10.192% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -6.249% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -59.217% |
| Biome Australia Limited | -1.91 Million AUD | -154.853% |
| Biotron Limited | -5.15 Million AUD | 5.343% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 66.83% |
| BTC Health Limited | 1.05 Million AUD | 562.05% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 60.389% |
| CSL Limited | 5.64 Billion AUD | 100.086% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 89.116% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 109.921% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 44.641% |
| Dimerix Limited | -25.05 Million AUD | 80.543% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 150.182% |
| Hexima Limited | -1 Million AUD | -383.366% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -69.67% |
| Immuron Limited | -5.8 Million AUD | 15.948% |
| Immutep Limited | -44.93 Million AUD | 89.149% |
| Imugene Limited | -140.93 Million AUD | 96.54% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -128.529% |
| Memphasys Limited | -2.7 Million AUD | -80.324% |
| Nanollose Limited | -1.24 Million AUD | -290.131% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 102.158% |
| Noxopharm Limited | -7.53 Million AUD | 35.289% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -137.093% |
| Nyrada Inc. | -4.56 Million AUD | -6.921% |
| Orthocell Limited | -11.68 Million AUD | 58.258% |
| PharmAust Limited | -6.65 Million AUD | 26.772% |
| Patrys Limited | -3.53 Million AUD | -37.772% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 92.511% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 32.574% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 32.15% |
| PYC Therapeutics Limited | -38.85 Million AUD | 87.452% |
| Race Oncology Limited | -13.38 Million AUD | 63.559% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 89.672% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 77.888% |
| Starpharma Holdings Limited | -15.15 Million AUD | 67.835% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 17.889% |